-
Building a global biotechnology powerhouse in Canada
-
Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval
-
Provincial investment boosts SFU’s research on optimizing uptake of new immune-based technologies
-
CIEBH Executive Director Michelle Wong honoured with 2024 UBC President’s Award
-
$31M provincial investment boosts Canada’s Immuno-Engineering and Biomanufacturing Hub at UBC
-
Canada’s $140 Million Investment Propels B.C. Towards Global Leadership in Life Sciences
-
Dermot Kelleher: Mpox outbreak underscores urgent need for rapid-response capability in Canada
-
Vancouver Nanomedicine Day is November 13
-
Hundreds of high-quality jobs in bioprinted tissue therapeutics coming to B.C.
